Pfizer Florida Medicaid Program Yields Savings Of $42 Mil. After Two Years
This article was originally published in The Pink Sheet Daily
Executive Summary
The company expects that the savings data exceeding the program's original goal will support a legislative change allowing Medicaid disease management programs in lieu of supplemental rebates to continue. The "Healthy State" initiative is slated to expire in September 2005.
You may also be interested in...
Employer Enthusiasm For Disease Management Is Waning, Insurers Say
PBMI Prescription Drug Utilization Conference attendees express caution about the motives of pharmaceutical manufacturer-sponsored disease management programs. Preliminary results from PBMI’s 2005 benefit design report found that a lower percentage of employers are using disease management programs.
Employer Enthusiasm For Disease Management Is Waning, Insurers Say
PBMI Prescription Drug Utilization Conference attendees express caution about the motives of pharmaceutical manufacturer-sponsored disease management programs. Preliminary results from PBMI’s 2005 benefit design report found that a lower percentage of employers are using disease management programs.
Pfizer Optimistic On Florida Medicaid Program As State Moves To Let Contract Expire
Legislation signed by Gov. Jeb Bush would end the Pfizer "Healthy State" program when the contract expires in September 2005. A state report suggests savings from the program have barely exceeded costs. Pfizer expects a report due in August to prove the value of its disease management initiative.